Syra Health Taps Marine Vet, Growth Expert as CEO to Scale Operations

CARMEL, Ind. – December 18, 2025 – Syra Health Corp. (OTCQB: SYRA), a Carmel-based healthcare solutions company, has appointed former U.S. Marine officer and seasoned healthcare executive Gregory R. Alexander as its new Chief Executive Officer, effective January 5, 2026. The move signals a strategic pivot toward aggressive growth for the micro-cap company as it aims to expand its footprint in the burgeoning population health market.

Alexander steps in at what the company describes as a “key moment” in its trajectory. While Syra Health reported a 45% revenue increase in 2024, recent quarters have been challenging, with Q3 2025 revenue seeing a 25% year-over-year decrease attributed to federal spending cuts affecting its government clients. The appointment of a CEO with a documented history of scaling organizations suggests the board is taking decisive action to navigate these headwinds and capitalize on the strong performance of its core business segments.

"After an extensive national search, we are pleased to welcome Greg to drive the Company's growth," said Dr. Avutu Reddy, speaking for the Syra Health Board of Directors. "Greg's exceptional track record includes expanding markets, tripling sales, and achieving #1 industry rankings at billion-dollar healthcare organizations. We believe his deep expertise... positions him to accelerate our growth strategy and deliver meaningful value for shareholders, clients, and the communities we serve."

A Mandate for Growth Forged in Healthcare's Trenches

Alexander’s resume reads like a playbook for scaling healthcare ventures. With over two decades of C-suite experience, his career is marked by significant, quantifiable achievements. As Chief Growth Officer at CitizensRx, a $500 million pharmacy benefits manager, he is credited with tripling sales. During his tenure at Lumeris, a $1.5 billion population health company, he oversaw the expansion of operations from three to 11 markets while growing its Medicare Advantage membership by over 20% annually.

This background in driving revenue and market share is precisely what Syra Health appears to need. Despite the recent top-line revenue dip, the company’s Population Health division has been a consistent bright spot, growing 96% year-over-year in Q3 2025. This segment, which focuses on delivering prevention-oriented solutions to large populations, aligns directly with Alexander’s deep experience in the Medicare and Medicaid markets, where Syra's primary customers operate.

His leadership style, which the company notes was shaped by his service as a Battalion Communications Officer in the United States Marine Corps, brings a layer of operational discipline that investors may find appealing. For a company that voluntarily delisted from Nasdaq in April 2025 and now navigates the OTCQB market, a leader known for executing targeted growth strategies and judiciously managing budgets could be pivotal in restoring market confidence and achieving sustainable profitability.

Aligning Expertise with a Tech-Forward Strategy

The strategic fit extends beyond general growth metrics into the very fabric of Syra Health’s product offerings. The global population health management market is projected to skyrocket from $87.2 billion in 2024 to over $346 billion by 2033, fueled by a shift to value-based care and the integration of artificial intelligence. Alexander’s most recent role as Senior Vice President of Commercial at Ellipsis Health, a voice AI company, places him at the forefront of this technological shift.

Syra Health has already invested heavily in AI, developing its own AI-backed products like Syrenity, a mental health platform, and SyraBot, a patient engagement chatbot. Alexander’s experience in commercializing AI solutions in healthcare could be instrumental in accelerating the adoption of these products. His expertise aligns perfectly with a market that increasingly demands sophisticated data analytics, predictive modeling, and digital tools to manage the health of entire communities proactively.

"I'm honored to join Syra Health at this key moment in the company's growth trajectory," Alexander stated. "The company's commitment to delivering customizable solutions that are affordable, accessible, and prevention-focused aligns perfectly with my passion for improving outcomes and creating value across the healthcare ecosystem."

Local Roots, National Ambitions

Beyond his corporate track record, Alexander’s deep ties to Indiana add another dimension to his appointment. As a long-time resident of Carmel, where Syra Health is headquartered, he brings an innate understanding of the local healthcare landscape. This is not just a symbolic connection; it is backed by substantial experience leading major healthcare initiatives within the state.

Previously, Alexander served as Market President at Evolent Health, where he supported Indiana University Health System's massive $600 million health plan. He also served as Executive Director for WellCare, launching its Medicare Advantage business in Indiana. This local expertise is particularly relevant given Syra Health’s recent successes in its home state, including a significant $5.8 million contract to train health workers serving Medicaid beneficiaries.

By appointing a leader with a proven ability to work with major local institutions, Syra Health reinforces its commitment to its home community while simultaneously building a model for national expansion. Alexander's ability to navigate the complexities of regional healthcare policy and provider networks could strengthen Syra's foundation in Indiana, providing a stable base from which to pursue its broader market ambitions. His appointment is a clear signal that the company intends to leverage its new leader's unique combination of global strategy, technological acumen, and local insight to power its next phase of growth.